Cornell researchers successfully ramped up the body’s own immune response to fight melanoma at the tail end of a targeted cancer therapy, when tumors commonly become resistant to these treatments.
Through their research programs, the 2026 fellows are advancing new tools and insights to inform conservation strategies, strengthen disease management, and promote sustainable systems that benefit wildlife, people, and the planet.
Vardan Khachatryan and Lilit Abrahamyan did not plan to stay in the U.S. when they left Armenia in 2016 and moved to Virginia. That changed in 2018, when they arrived in Ithaca.
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to NSE-FAST®, the first rapid blood test designed to aid in the diagnosis of acute ischemic stroke.
A Cornell-led study is challenging a decades-old explanation for how chromosomes exchange genetic material within the biological process that forms eggs and sperm in mammals.
Marx will establish and serve as inaugural director of the Cornell Center for Entrepreneurship and Innovation, to boost university efforts to commercialize breakthrough scientific discoveries.
A $13.3 million grant from the NIH will support efforts to reveal how immune cells communicate within living tissues, which could shape new approaches for treating inflammatory diseases, autoimmune disorders and infections.
